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Abstract
Circulating RNA may result from excessive cell damage or acute viral infection and can interact with vascular endothelial
cells. Despite the obvious clinical implications associated with the presence of circulating RNA, its pathological effects on
endothelial cells and the governing molecular mechanisms are still not fully elucidated. We analyzed the effects of double
stranded RNA on primary human pulmonary artery endothelial cells (hPAECs). The effect of natural and synthetic double-
stranded RNA (dsRNA) on hPAECs was investigated using trans-endothelial electric resistance, molecule trafficking, calcium
(Ca2+) homeostasis, gene expression and proliferation studies. Furthermore, the morphology and mechanical changes of the
cells caused by synthetic dsRNA was followed by in-situ atomic force microscopy, by vascular-endothelial cadherin and F-
actin staining. Our results indicated that exposure of hPAECs to synthetic dsRNA led to functional deficits. This was reflected
by morphological and mechanical changes and an increase in the permeability of the endothelial monolayer. hPAECs
treated with synthetic dsRNA accumulated in the G1 phase of the cell cycle. Additionally, the proliferation rate of the cells in
the presence of synthetic dsRNA was significantly decreased. Furthermore, we found that natural and synthetic dsRNA
modulated Ca2+ signaling in hPAECs by inhibiting the sarco-endoplasmic Ca2+-ATPase (SERCA) which is involved in the
regulation of the intracellular Ca2+ homeostasis and thus cell growth. Even upon synthetic dsRNA stimulation silencing of
SERCA3 preserved the endothelial monolayer integrity. Our data identify novel mechanisms by which dsRNA can disrupt
endothelial barrier function and these may be relevant in inflammatory processes.
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Introduction
Endothelial function is essential for vascular integrity. The
endothelium provides a barrier, regulates vascular tension, and is
involved in angiogenesis and haemostasis. Local and systemic
inflammation, however, can impair endothelial function and can
lead to cellular damage increasing endothelial permeability and
loss of epithelial barrier function [1,2]. Endogenous RNA release
and circulating RNA like virus–associated double stranded RNA
(dsRNA) may contribute to the development of endothelial
dysfunction. Endothelial cells express toll-like receptor 3 (TLR3)
[3] which is activated by dsRNA [4,5]. The activation of TLR3
affects cell homeostasis [6,7] and causes changes at functional
[8,9], as well as inflammatory gene expression level [10]. At
cellular level, dsRNA induces a signaling cascade [11,12] leading
to TLR3 receptor upregulation [4,13]. At organ level, repeated
and long-term administration of synthetic dsRNA causes inflam-
mation [14,15] and leads to impairment of lung function in mice
[16–18]. However, the biological activity of circulating extracel-
lular RNA is poorly understood.
Recently, an extracellular RNA-induced activation of VEGF
has been shown, leading to increased permeability of cerebral
endothelial cells, which are the main components of the blood
brain barrier [19]. This hyperpermeability can occur due to
exposure of the cells to total RNA [8] or the synthetic analogue of
dsRNA, polyinosinic-polycytidylic acid (Poly I:C) [20] and can
lead to disintegration of adherens junctions [21]. Endothelial
permeability regulation [22] and function [23,24] is a Ca2+-
dependent process [1,25]. A rise in intracellular Ca2+ in the ECs
occurs through Ca2+ influx or by release from the sarco-
endoplasmic reticulum (SER) resulting in plasma membrane-
located Ca2+ channel activation [26,27]. To maintain the Ca2+
homeostasis of the cell, the Ca2+ stores are refilled by the SER-
membrane-located sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA) [28]. SERCA is encoded by three homologous genes:
SERCA1, SERCA2 and SERCA3 [29], out of these in human
pulmonary artery endothelial cells (hPAECs) only SERCA2 and
SERCA3 isoforms are expressed [30,31]. However, SERCA plays
an important role not only in the Ca2+ homeostasis [24,30,32], but
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it is vital for cell cycle control [33], proliferation and regulation of
cellular permeability as well.
In the present study we investigated alternative pathways of
dsRNA on primary hPAECs. Changes in cell morphology,
permeability, cellular junctions, mechanical properties and Ca2+
homeostasis were characterized. Furthermore, we assessed the
effects of natural and synthetic dsRNA on gene expression,
proliferation of hPAECs and on SERCA.
Materials and Methods
Cell Culture
Human pulmonary artery endothelial cells (hPAECs) were
obtained from Lonza (Allendale, New Jersey) and they were
cultured according to the manufacturer’s instructions. The
endothelial specific media (VascuLife, Lifeline) was changed every
third day. Cells in passages 5–9 were used for the experiments and
the endothelial phenotype was regularly checked for von Will-
ebrand factor expression.
Solutions and Chemicals
Poly I:C was purchased from Amersham Pharmacia, L-DNA
from Fermentas (SD0021), LY-294002 and 2,5-Di-t-butyl-1,4-
benzohydroquinone (BHQ) was received from Sigma. Double-
stranded RNA (sense: 59-UAC-ACC-GUU-AGC-AGA-CAC-
CdTdT-39, antisense: 59-GGU-GUC-UGC-UAA-CGG-UGU-
AdTdT-3) was from Qiagen. Total cellular RNA was isolated
from hPAECs with the RNeasy Mini Kit (Qiagen). PhosphoAKT
and AKT antibodies were obtained from Cell Signalling
Technology Inc. All chemicals were dissolved and diluted to the
desired concentration in experimental solution containing in mM:
145 NaCl, 5.5 KCl, 1.8 CaCl2, 1 MgCl2, 10 Glucose and 10
HEPES. The pH was set to 7.4. All the solutions were freshly
prepared on the day of the experiment and stored at 4uC until they
were used. The experiments were carried out at room temperature
unless otherwise stated.
Transendothelial Electrical Resistance Measurement
(TEER)
For measuring the cellular barrier properties hPAECs were
grown until confluence on semi-permeable inserts. The TEER was
measured using an Endohm chamber connected to an EVOM
resistance meter (World Precision Instruments, Sarasota, USA)
and TEER values were recorded every 30 min for the first 5 hours
and additionally at 18, 20, 22 and 24 hour timepoints after
treatment with 25 mg/mL Poly I:C, 25 mg/mL dsRNA, 2.5 mg/
mL totalRNA, 2.5 mg/mL L-DNA or control solution. The
measurements were carried out at 37uC. The resistance of a blank
filter insert filled with the control media was subtracted as
background value from the total resistance of each culture insert
[34].
Permeability Measurement with Fluorescently Labelled
Dextran
To assess the permeability changes of the endothelial monolay-
er, hPAECs were grown until confluence on semi-permeable
inserts and incubated for 24 h with 25 mg/mL Poly I:C, 25 mg/
mL dsRNA, 2.5 mg/mL totalRNA, 2.5 mg/mL L-DNA, 25 mM
LY-294002, 30 mM BHQ or control solution (vehicle control).
After treatment, FITC-labelled dextran was added to the upper
compartment of the insert (ECM640 In Vitro Vascular Permeabil-
ity Assay Kit, Chemicon). The fluorescence of the solution from
the bottom well was measured with a fluorescent plate reader
(lex = 485 nm, lem=525 nm; Optima, BMG Labtech).
Quantitative RT-PCR
For quantitative RT-PCR and as a stimulation agent, total
cellular RNA from hPAECs was isolated with the RNeasy Mini
Kit from Qiagen. The protocol for purification of total RNA from
cells using spin technology was followed (Cat. No./ID: 74104).
Additionally, DNase digestion during RNA isolation was carried
out with the RNase-Free DNase-Set from Qiagen (Cat. No./ID:
79254). The Agilent 2001 Bioanalyzer and Agilent RNA 6000
Nano Assay Protocol were used to quantify the concentration and
the purity of the isolated total RNA. The total cellular RNA
isolated from endothelial cells was converted to cDNA using a
RevertAid H Minus First Strand cDNA Synthesis kit (Fermentas).
PCR amplifications were performed by AB7900 (Applied Biosys-
tems) using the following primers: Hs_GAPDH_2_SG
(QT01192646) - GAPDH, Hs_ATP2A3_1_SG (QT00087220) -
SERCA3; Hs_ATP2A2_1_SG (QT00077231) - SERCA2; and the
SYBR Green I Master Mix (Qiagen). Amplifications were
performed in triplicates and the mean threshold cycle (Ct) reading
was used. Gene expressions were quantified relative to the
housekeeping gene (GAPDH) and normalized to the expression
level of untreated control samples (delta-delta Ct method).
Immunofluorescent Staining
HPAECs were seeded on chamber slides and were grown until
confluence then they were treated for 24 h with 25 mg/mL Poly
I:C, 25 mg/mL dsRNA, 2.5 mg/mL totalRNA, 2.5 mg/mL L-
DNA, 25 mM LY-294002, 30 mM BHQ or kept untreated
(control). The cells were fixed with a buffer containing 100 mL
phosphate buffered saline solution (PBS) pH 7, 650 mg Na2HPO4,
400 mg NaH2PO4, 1.5 mL Methanol, 10 mL 4% Formaldehyde.
The slides were washed with pre-warmed Hepes buffered saline
solution (HBSS) for 20 min at room temperature (RT). After
washing the cells for 5 min in PBS, they were covered for 30 min
with 100 nM Glycerol (RT). 365 min washing steps with PBS
were performed and followed by permeabilization with 0.1%
Triton-X-100 for 30 min at RT. Afterwards 365 min PBS
washing steps were performed. The cells were blocked for
30 min with 3% BSA in PBS at RT, than they were washed
again for 5 min. The primary antibody (VE-Cadherin, 1:200
dilution, Abcam; ZO-1, 1:100 dilution, Zymed) was added to the
cells for 30 min (RT). After washing for 365 min, the cells were
incubated at RT for 30 min with goat anti-mouse antibody
conjugated with AF-594 (1:500 dilution, Molecular Probes) in
dark. Finally, the cells were counterstained with DAPI to identify
the nuclear DNA. Duplicates processed without primary antibod-
ies served as negative controls. Fluorescence was imaged using a
Zeiss 200 M inverted epifluorescent microscope.
For phalloidin staining the cells were fixed with 4% formalde-
hyde for 30 min at 4uC, permeabilized using acetone at220uC for
10 min. After blocking with 3% bovine serum albumin for 30 min,
the coverslips were incubated with Alexa488-phalloidin (Molecu-
lar Probes). Mounting was performed in anti-fading embedding
medium (Biomeda) and the distribution of the signal was imaged
using a Nikon Eclipse TE2000U photomicroscope with epifluor-
escent capabilities connected to a digital camera (Spot RT KE).
Western Blotting
Protein extracts were prepared from hPAECs in RIPA buffer
containing Protease-Inhibitor and Phosphatase-Inhibitor tablet
(Roche, Vienna, Austria). Equivalent amounts of protein were
resolved on 10% SDS polyacrylamide gels and proteins were
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transferred to the nitrocellulose membrane. Nonspecific antibody
binding was blocked by incubation in 5% (m/v) non-fat dry milk
powder in TBST (20 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.1%
(v/v) Tween 20) at room temperature for 1 h. Afterwards, the
blots were incubated overnight with a 1:1000 diluted primary
antibody at 4uC. After washing the membranes in TBST buffer
and incubating with 1:2000 diluted horseradish-peroxidase con-
jugated anti-IgG secondary antibody for 1 h at room temperature,
specific immunoreactive signals were detected by enhanced
chemiluminescence (ECL, Amersham, Freiburg, Germany).
Live Cell Ca2+ Imaging
The cells were cultured on gelatine coated, 25 mm glass cover
slips. After reaching confluence, they were treated for 24 h with
25 mg/mL Poly I:C, 25 mg/mL dsRNA, 2.5 mg/mL L-DNA,
2.5 mg/mL total RNA or left untreated (control). The cover slips
were loaded with fura-2/AM (2 mmol/L) in dark for 45 min
followed by a washing step in experimental solution as previously
described [35]. After 15 min, the single glass cover slip was
mounted on the stage of a Zeiss 200 M inverted epifluorescence
microscope coupled to a PolyChrome V monochromator (Till
Photonics, Germany) light source in a sealed temperature-
controlled RC-21B imaging chamber (Warner Instruments,
USA) and perfused with prewarmed solution (30uC). Fluorescence
images were obtained with alternate excitation at 340 and
380 nm. The emitted light was collected at 510 nm by an air-
cooled Andor Ixon camera (Andor Technology, Ireland). Mea-
surements were made every 3 s. Background fluorescence was
recorded from each cover slip and subtracted before calculation.
The acquired images were stored and processed offline with
TillVision software (Till Photonics, Germany). [Ca2+]i was
calculated as described by Grynkiewicz et al. [36]. Maximal and
minimal ratio values were determined at the end of each
experiment by first treating the cells with 1 mmol/L ionomycin
(maximal ratio) and then chelating all free Ca2+ with 10 mmol/L
EGTA (minimal ratio). Cells that did not respond to ionomycin
were discarded.
The cells were stimulated with 100 mM histamine or 15 mM
2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ: selective SERCA
blocker) in the presence and absence of extracellular Ca2+, after
incubation for 24 h with 25 mg/mL Poly I:C, 25 mg/mL dsRNA,
2.5 mg/mL L-DNA, 2.5 mg/mL total RNA or control solution.
Live Cell Atomic Force Microscopy Measurements
The measurements were performed with an Asylum MFP-3D
head and Molecular Force Probe controller (Asylum Research,
Santa Barbara, CA, USA). The driver program MFP Xop was
written in IGOR Pro software (version 5.0.3, Wavemetrics, Lake
Oswego, OR, USA). The MFP-3D head was mounted on a Zeiss
Axiovert 200 invert optical microscope. The cells were cultured on
gelatine-coated 15 mm diameter glass cover slips until confluence.
The sample was mounted on the stage of the microscope and
contact mode image and force curve acquisition was performed.
Afterwards the cells were treated with 25 mg/mL Poly I:C or left
untreated (control). The image and force curve acquisition was
repeated every 30 min for 3 hours. For imaging in solution, gold
coated, silicon nitride, rectangular cantilevers were used (Bio-lever,
BL-RC150 VB-C1, Olympus Optical Co. Ltd., Tokyo, Japan).
The imaging in solution and the determination of the Young’s
moduli were made as previously reported [37,38].
Cell Growth and Proliferation Assays
Cells were plated at a density of 104 cells/well in 2%FBS/
Medium in 96-well plates and were allowed to adhere overnight.
The concentration- dependent effect of 24 h incubation with Poly
I:C, dsRNA, totalRNA, L-DNA, LY-294002 or BHQ on growth
and proliferation of hPAECs was determined by [3H]thymidine
incorporation as an index of DNA synthesis. [3H]thymidine
(0.2 mCi/well) was added for the last 16 h. After 24 h incubation
the cells were harvested and transferred to filter-plates. The
radioactivity was measured using a beta-counter.
Flow Cytometry
To measure the cell-cycle dependent amount of DNA per cell,
propidium-iodide staining was performed on methanol-fixed
hPAECs after 24 h incubation with Poly I:C or control solution.
The cells were trypsinized, centrifuged for 5 min at 2206g at 4uC,
and then washed with 10 ml PBS. The pellet was re-suspended
and again centrifuged for 5 min at 2206g at 4uC and dissolved in
500 ml PBS. For 106 cells 5 mL of 70% ice cold methanol was
added for 10 min at 4uC. For data analysis the FCA3.3 DNA subG1
protocol was used.
Transfection of Small Interfering RNA against SERCA3
Small interfering RNAs (siRNA) against SERCA3 were
commercially synthesized (siSERCA3, sc-41295, Santa Cruz
Biotechnology). As negative control, non-silencing RNA (siCTL,
Control siRNA-A, sc-37007, Santa Cruz Biotechnology) which
does not target any human gene product was used. Either 200 nM
siCTL or 200 nM siSERCA3 was mixed with 500.000 hPAECs
and 100 ml of Basic Nucleofector Solution from Basic Endothelial
Cells Nucleofector Kit (Lonza). This mixture was electroporated
according to the manufacturers’ instruction. Knock-down was
confirmed by quantitative RT-PCR and western blot with specific
primers and antibody. Permeability measurement with fluores-
cently labelled dextran and VE-cadherin staining were performed
48–56 h post transfection.
Statistical Analysis
Numerical values are given as means 6 SD of n cells.
Intergroup differences were assessed by factorial analysis of
variance with post hoc Fisher’s least significant difference test or
Student’s t-test (p values ,0.05 were considered significant).
For the live cell Ca2+ imaging data analysis, the basal level of
Ca2+ was determined as an average value of the first 50 seconds of
the curve. Afterwards, the histamine-induced Ca2+ peak height
after subtracting the baseline as well as the plateau duration of the
Ca2+ response were quantified. The plateau duration is the time
from the maximum Ca2+ peak height until the intracellular Ca2+
declines to the basal level.
To determine the blocking potency of Poly I:C on hPAECs
proliferation, concentration–inhibition curves were constructed
from the FCS-induced hPAECs proliferation in the presence of
different drug concentrations in the media. The proliferation
values are given in the presence of Poly I:C as a fraction of the
FCS-induced proliferation in the absence of Poly I:C. The
normalised values were fitted by means of a nonlinear least-
squares method with the equation: 1(1+c(IC50)–1)h)–1, where c
was the drug concentration, IC50 was the concentration giving a
half-maximum effect and h was the Hill coefficient. Because the
Hill coefficient was less than 1, it was set to one, accounting for a
1:1 binding stoichiometry.
Dual Effect of dsRNA on SERCA in Human PAECs
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Results
Modulation of the Human Pulmonary Artery Endothelial
Monolayer Integrity by Double-stranded RNA
Double-stranded RNA (dsRNA) or its synthetic analogue (Poly
I:C) significantly decreased the electric resistance and increased
the permeability of the confluent human pulmonary artery
endothelial (hPAEC) monolayer as shown on Figure 1. Primary
hPAECs were incubated with dsRNA or Poly I:C up to 24 hours
and the transendothelial electric resistance (TEER) was measured
(Figure 1A). L-DNA, which is not a toll-like receptor 3 ligand [8],
was used as a control. Significant decrease in TEER was observed
already after 18 hours of treatment suggesting that both, dsRNA
and Poly I:C disrupted the integrity of the endothelial monolayer.
In contrast, the incubation with L-DNA had no significant effect.
Consistently, the trafficking of FITC-labeled dextran molecules
through the confluent endothelial monolayer was significantly
increased after 24 h dsRNA, Poly I:C or total RNA application
(Figure 1B, 131630%, 140623% and 152645% of control,
respectively). 24 h incubation with L-DNA had no significant
effect (98615% of control).
An elongation of the Poly I:C treated cells and the appearance
of rearranged fiber structures was observed on the actin staining
(Figure 2A, B) and more prominently in the live cell atomic force
microscopy images (Figure 2C, D). The representative amplitude
image of the control hPAECs showed a regular cell shape as seen
in Figure 2C, whereas elongated cells were detected on the images
taken from the 24 h Poly I:C treated culture (Figure 2D). The Poly
I:C treatment was also associated with a time dependent stiffening
of the cells (Figure 2E). The Young’s moduli of the hPAECs was
determined by direct force measurements on 5 distinct points
above the nuclear region of the numbered cells shown in Figure 2C
and D. A significant increase in the Young’s moduli from
0.2560.15 kPa to 2.1561.5 kPa upon 24 h Poly I:C treatment
was observed (Figure 2E).
The integrity of the intercellular junctions was further
investigated by vascular endothelial-cadherin (VE-cadherin) and
Zonula occludens 1 (ZO-1) staining. The continuous membrane
staining for both VE-cadherin and ZO-1 showed colocalization of
these two proteins (Figure 3A). 24 h of Poly I:C treatment caused
disruption of the endothelial barrier integrity. The VE-cadherin
and ZO-1 membrane staining either disappeared or became
discontinuous (Figure 3B).
Involvement of Phosphatidylinositol 3-Kinase in the Poly
I:C induced Endothelial Dysfunction
Next, we investigated the TLR3 - Phosphatidylinositol 3-Kinase
(PI3-Kinase) driven regulation of endothelial permeability and
proliferation. Poly I:C treatment resulted in a 35-fold upregulation
of TLR-3 in hPAECs (Figure S1, Methods S1). However, both
VE-cadherin and ZO-1 stainings (Figure 3A) showed a cumulative
effect of Poly I:C and LY-294002 (PI3-Kinase blocker) with a total
disappearance of both proteins from the cell membranes.
Consistently, the FITC-labelled dextran traffic was significantly
increased by 24 hours of LY-294002 (152.10624.18%) and this
effect was additive with the Poly I:C effect, leading to a
501.8068.27% increase in the amount of transmitted fluorescent
dextran molecules (Figure 3B). Additionally, the proliferation of
the hPAECs was blocked to 50.73610.32% by LY-294002,
similar to the Poly I:C effect (44.74615.92%) and further inhibited
to 24.9567.44% when both compounds were administered
together (Figure 3C).
Effect of dsRNA on the Cell Cycle of hPAECs
The 24 h Poly I:C or dsRNA treatment reduced dose-
dependently the FCS-induced hPAECs proliferation (Figure 4A),
whereas L-DNA had no significant effect. The concentration-
response curve of the Poly I:C-induced inhibition of proliferation
resulted in an IC50 of 2.060.3 mg/mL (Figure 4A; n = 5 for each
group).
Furthermore, upon Poly I:C treatment a dose- and time-
dependent accumulation of hPAECs in the G1-phase was
observed (Figure 4B). The number of cells in the G1 phase was
significantly increased from 62.460.3% (control) to 76.961.8%
after 24 h and further raised to 91.561.1% after 48 h of treatment
with 25 mg/mL Poly I:C. This increase was accompanied by a
decrease in the number of cells both, in the S and in the G2/M
phase.
Figure 1. Double-stranded RNA decreased transendothelial
electric resistance and increased FITC-dextran permeability
through hPAECs monolayers. (A) Both natural double-stranded RNA
(squares) and synthetic analogue (Poly I:C, circles) caused a significant,
time dependent, linear decrease of the transendothelial electric
resistance (TEER) of the human pulmonary artery endothelial cell
(hPAEC) monolayer. L-DNA served as a control and had no significant
effect. The graph summarizes the results of 6 independent measure-
ments for each treatment and the linear fit of the data. The values were
normalized to the TEER of hPAECs at the start of the experiment
(*p,0.05, ***p,0.001 compared to Vehicle control). (B) Histogram
summarizing the effect of the 24 h treatments on the FITC-dextran
permeability of hPAEC. Double-stranded RNA significantly increased
FITC-dextran traffic. Similar results were obtained after Poly I:C and total
RNA treatment, but not with L-DNA. Values represent 3 independent
experiments, each performed in triplicates and they were normalized to
the vehicle control (*p,0.05 compared to Vehicle control).
doi:10.1371/journal.pone.0063776.g001
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Impact of dsRNA on Intracellular Ca2+ Homeostasis and
SERCA Activity of hPAECs
Because changes in intracellular Ca2+ concentration affect cell
proliferation, the role of dsRNA on [Ca2+]i was further analyzed in
hPAECs. Independently of the extracellular Ca2+ concentration,
there was no significant effect on the resting Ca2+ concentration
(Table 1) and on the 100 mM histamine-induced peak Ca2+
concentration of the cells (Table 2). In contrast, 24 h dsRNA
incubation significantly prolonged the 100 mM histamine-induced
Ca2+ signal in the absence (Figure 5A) or presence of extracellular
calcium (Figure 5C). Similar results were observed with Poly I:C,
whereas L-DNA incubation had no effect (Figure 5). This
prolonged Ca2+ signal (Figure 5B, D) suggested that dsRNA
treatment caused a delay in the clearance of cytoplasmic Ca2+,
which is necessary for replication.
To further investigate the effect of dsRNA on the sarco-
endoplasmic reticulum Ca-ATPase (SERCA), gene expression
analysis was performed. Both SERCA isoforms (SERCA2b and 3)
present in hPAECs showed a significant decrease in mRNA
expression after 24 h of Poly I:C treatment (Figure 5E, F;
0.3760.19 fold change for SERCA 2b and 0.3360.13 for
SERCA3). Treatment with the PI3 kinase blocker (LY-294002)
caused a similar decrease in the SERCA expression
(0.2460.03 for SERCA 2b and 0.3360.09 for SERCA3). Fur-
thermore, the combination of LY-294002 and Poly I:C showed a
cumulative effect (Figure 5E, F, 0.1860.01 for SERCA 2b and
0.1460.04 for SERCA3). In contrast, L-DNA did not alter the
expression levels of these genes (0.9060.03 for SERCA 2b and
1.0460.73 for SERCA3).
Next, the effect of Poly I:C and dsRNA treatment on the
phosphorylation of phospholamban, an endogenous inhibitor of
SERCA was assessed. After 24 h treatment a significant decrease
in the phospholamban phosphorylation was observed (Figure 5G,
H).
While an inhibitory effect of dsRNA on the SERCA pump was
expected, we investigated the SERCA blocker (BHQ) induced
dose-dependent inhibition of the hPAEC proliferation (Figure 6A).
The effect was similar to that of dsRNA or Poly I:C (Figure 4A).
BHQ treatment led to disruption of the VE-cadherin staining
similar to Poly I:C or LY-294002 (Figure 6C). This effect was
accompanied by increase in the endothelial permeability
(Figure 6B) pointing to decreased endothelial barrier function.
Next, we investigated the effect of Poly I:C after siRNA silencing
of SERCA3 on hPAECs (Figure 7). The observed increase in
permeability upon 25 mg/mL Poly I:C treatment on siCTL
hPAECs, was significantly reduced with the silencing of SERCA3
(Figure 7A). Parallel, confocal microscopic images revealed that
knock down of SERCA3 caused less VE-cadherin signal loss upon
24 h Poly I:C stimulation as compared to siCTL (Figure 7C). The
silencing of SERCA3 confirmed the previous findings obtained
with the SERCA blocker, BHQ.
Altogether, these data suggest that synthetic dsRNA treatment
alters the function of SERCA, which inhibits cell proliferation by
inducing G1 arrest in the hPAECs and contributing to endothelial
dysfunction.
Figure 2. Actin rearrangement and stiffening of hPAECs under stimulation with Poly I:C. Actin rearrangement (green) showing changes in
the cell shape (A - control, B - 24 h after Poly I:C). Nuclei were counterstained with DAPI (blue). (C) Representative 80680 mm2 amplitude atomic force
microscope image of hPAEC culture without (Control) and with 24 h Poly I:C treatment (D). (E) The force measurements (performed on 5 different
points in the central region of numbered cells) showed a significant increase in the Young’s moduli of the cells (***p,0.001 compared to Control).
doi:10.1371/journal.pone.0063776.g002
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Figure 3. Involvement of PI3 kinase in the Poly I:C induced cell-cell contact disruption and permeability increase. (A) 24 h LY-294002
(PI3 kinase blocker) treatment along with Poly I:C (third column) reduced the VE-cadherin and ZO-1 signal similarly to 24 h Poly I:C treatment (second
column) compared to control (first column). (B) LY-294002 significantly increased the FITC-dextran permeability of hPAEC, comparably to Poly I:C
effect. The bar graph summarizes 3 independent experiments each performed in triplicates. (C). 24 h LY-294002 treatment significantly reduced
hPAEC proliferation compared to Vehicle control. A similar and additive effect of 24 h Poly I:C treatment has been observed (**p,0.01, ***p,0.001
compared to Vehicle control).
doi:10.1371/journal.pone.0063776.g003
Dual Effect of dsRNA on SERCA in Human PAECs
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Discussion
The major function of the vessel-forming endothelial cells is to
maintain the blood-tissue barrier. Viral RNA has been identified
as a pathogenic factor in different pulmonary diseases [39,40].
Circulating RNA may lead to pulmonary endothelial dysfunction
and thus to increased endothelial permeability [8]. The precise
mechanism by which circulating RNA induces endothelial barrier
disruption in the lung has not been completely understood yet.
The present study addressed novel pathways of dsRNA effect on
Figure 4. Proliferation inhibition of hPAEC by natural and synthetic dsRNA. (A) Concentration dependent inhibition of the hPAEC
proliferation upon Poly I:C administration. The line is the best fit to the Hill equation with an IC50 of 2.060.3 mg/mL. The bar graph summarizes the
effect on hPAEC proliferation of Poly I:C, double-stranded RNA and L-DNA treatment. The graphs represent 3 independent experiments, each
performed in triplicates (**p,0.01, ***p,0.001 compared to Vehicle control). (B) Histogram summarizing the effect of Poly I:C treatment on the cell
number distribution in G1, S and G2/M phase of cell cycle. The graph represents 3 independent experiments of flow-cytometric analysis of propidium
iodide stained cells.
doi:10.1371/journal.pone.0063776.g004
Table 1. Basal Ca2+ concentration of hPAECsin the presence
and absence of extracellular Ca2+.
Protocol
Baseline
(nM Ca) SD Nr. of cells
Ca2+ control 128.21 75.89 41
Ca2+-free control 134.13 90.84 59
Ca2+-free Poly I:C 108.43 77.90 44
Ca2+ Poly I:C 110.72 110.92 29
doi:10.1371/journal.pone.0063776.t001
Table 2. Histamine induced Ca2+ peak height of hPAECs in
the presence and absence of extracellular Ca2+.
Protocol
Peak height
(nM Ca) SD Nr. of cells
Ca2+ control 364.16 162.99 33
Ca2+-free control 383.24 299.02 41
Ca2+-free Poly I:C 326.14 250.09 24
Ca2+ Poly I:C 312.74 127.09 22
doi:10.1371/journal.pone.0063776.t002
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primary human pulmonary artery endothelial cells (hPAECs). Our
data showed that natural dsRNA treatment significantly decreased
electric resistance indicating disruption in the hPAEC monolayer
integrity. A similar effect could be observed with the widely used
synthetic dsRNA-analog, Poly I:C. Incubation with L-DNA did
not cause significant permeability changes indicating the specificity
of the dsRNA effect. As dsRNA and Poly I:C treatment mimics
viral infection, our results are in line with previous observations on
bluetongue virus-infected human primary microvascular endothe-
lial cells [41]. The EC monolayer disrupting effect of dsRNA was
further confirmed by using fluorescently labeled dextran traffick-
ing, showing that stimulation with either Poly I:C, total RNA or
dsRNA resulted in an increase in transferred dextran amount
suggesting a significant loss in endothelial barrier function.
The tight, isolating monolayer of the endothelial cells is
accomplished by junctional structures, like adherens and tight
junctions. The major component for the maintenance of
monolayer integrity belongs to the transmembrane protein family,
the cadherins [21]. The vascular endothelial cells express in their
membrane the vascular endothelial cadherin (VE-cadherin)
member of this family. Poly I:C incubation decreased VE-cadherin
signal, pointing to disrupted cell-cell contacts in the monolayer. A
similar decrease was reported as a result of dengue-2 virus
infection in human umbilical vein endothelial cells [21]. We
observed a similar decrease in the ZO-1 protein upon Poly I:C
treatment. Furthermore, our results indicate that not only the
junctional proteins contribute to dissociation of intercellular
contacts, but also the actin reorganization. The Poly I:C treated
cells presented with an intense peripheral actin staining accom-
panied by cellular shape changes visible on the immunofluorescent
pictures. Similar cytoskeletal rearrangement was shown to be
induced by 6 h bluetongue virus infection in primary human
microvascular endothelial cells [41]. Although, the authors report
on a recovery of both electrical resistance and actin/VE-cadherin
staining after 24 h, this was not the case in either dsRNA, or Poly
I:C treatment in our experiments. This could be explained by the
differences between the human lung microvascular and arterial
endothelial cells.
To investigate the possible involvement of the PI3-kinase
pathway in the Poly I:C induced permeability and structural
changes, we tested the effect of a PI3-Kinase blocker (LY-294002)
on permeability, proliferation and junctional staining. It has been
shown that the TLR3 - PI3-Kinase pathway could be involved in
the dsRNA induced signalling [42]. Indeed, we observed an
upregulation of the TLR3 receptor upon Poly I:C treatment. The
block of PI3-Kinase resulted in increased hPAEC permeability,
decreased proliferation and disruption of VE-cadherin and ZO-1
staining. On primary hPAECs, the blocking was additive to the
effect of Poly I:C, pointing to a PI3-Kinase independent
mechanism of action. However, others report that PI3-Kinase is
involved in dsRNA signalling [42]. In their study, a mammalian
heterologuos expression system (HEK293) was used with a higher
concentration of Poly I:C. We could confirm the inhibitory effect
of PI3-kinase on SERCA expression, as it was previously reported
with a PI3-kinase inhibitor on SERCA dependent calcium
handling [43]. However, the effect on downregulation of both
isoforms was additive pointing to a PI3-Kinase independent
mechanism of action, similar to the effects we observed on
hPAECs permeability and proliferation.
Structural changes caused by inflammatory stimuli may lead to
dissociation of cell-cell junctions leading to a widened intercellular
space that facilitates transendothelial flux [1]. We observed similar
structural rearrangement in light microscopy: the Poly I:C treated
cells presented a morphological change with an elongated shape.
In-situ atomic force microscopy (AFM) imaging and force
measurements detected structural changes in the endothelial cells
at single cell level. Endothelial barrier-disruptive agents have been
reported to cause changes in cytoskeletal mechanics of hPAECs
[44]. In our AFM images, cells treated with Poly I:C showed an
elongated morphological shape. Furthermore, the Poly I:C
treatment also led to an approximately 10-fold stiffening of the
cells. This is in line with the observations of the effect of other
barrier-disruptive agents on hPAECs [44,45]. The change in the
mechanical properties of the cells can lead to disturbed or
disrupted cell-cell contacts and may contribute to endothelial
dysfunction.
A critical factor for the regular endothelial function is the Ca2+
homeostasis [25]. Our data suggest that, beside structural changes,
Poly I:C and dsRNA also affects endothelial Ca2+ homeostasis.
Acute administration of either Poly I:C, or dsRNA did not result in
any Ca2+ response, but 24 hours of treatment led to a significantly
prolonged histamine-induced Ca2+ response, without affecting the
basal Ca2+ level. Further, we focused on intracellular Ca2+
mobilization. The key player of the Ca2+ store refilling is the sarco-
endoplasmic reticulum Ca-ATPase (SERCA) [28] and its proper
regulation is vital for normal cell function [33]. An inhibitory effect
of Poly I:C on SERCA is suggested by the increased duration of
the histamine-induced signal, observed in the presence and
absence of extracellullar Ca2+. We observed a decrease in the
phospholamban phosphorylation upon Poly I:C or dsRNA
treatment, which contributes to enhanced block of SERCA
function. Phospholamban is a negative regulator of SERCA
function [46]. Phospholamban phosphorylation causes its dissoci-
ation from SERCA and removes inhibition [47].
RT-PCR showed a decrease in the expression of both
isoenzymes of SERCA upon Poly I:C treatment. However, upon
dsRNA treatment no changes in the gene expression could be
observed. Thus, our data indicate, that dsRNA does not regulate
SERCA expression like its synthetic analogue (Poly I:C).
Nonetheless, both caused decrease in the phospholamban
phosphorylation. Furthermore, the SERCA blocker (BHQ)
induced a dose-dependent inhibition of the hPAEC proliferation,
a decrease in the VE-cadherin staining and increase in the
transendothelial transport similar to the effect of dsRNA or Poly
I:C. The siRNA silencing of SERCA3 on hPAECs confirmed the
Figure 5. Prolonged histamine-induced Ca2+ plateau in hPAECs after Poly I:C incubation accompanied by SERCA downregulation
and phospholamban dephosphorylation. Representative traces of 100 mM histamine induced intracellular Ca2+ rise under Ca2+-free (A) and Ca2+
(C) conditions showed a prolonged decay of intracellular Ca2+ level in hPAECs after 24 h Poly I:C (red line), dsRNA (green line) or total RNA (orange
line) treatment. As a control, L-DNA had no effect (blue line). Arrow indicates the application of histamine (His). (B) The histamine induced transient
Ca2+ plateau duration was significantly longer in the case of treatment (*p,0.05, **p,0.01, ***p,0.001 compared to Control, untreated sample) in
the absence (B) and presence (D) of 1.8 mM extracellular Ca2+. Bar graphs show expression of SERCA3 (E) and SERCA2b (F) isoform of the sarco-
endoplasmic reticulum Ca2+ ATPase pump. Results are from 3 independent experiments each performed in triplicates (**p,0.01, ***p,0.001
compared to Vehicle control). (G) Phospholamban phosphorylation upon 24 h Poly I:C and dsRNA treatment (p-PLB - phosphorylated
phospholamban). (H) Bar graph represents p-PLB/a-tubulin ratio from 3 independent western blot experiments (***p,0.001 compared to Vehicle
control).
doi:10.1371/journal.pone.0063776.g005
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involvement of SERCA in the Poly I:C induced endothelial
dysfunction.
Our data indicate that Poly I:C induces G1 arrest in the
hPAECs by inhibiting the function of SERCA, which is vital for
cell cycle control. In rat aortic endothelial cells, a decrease in
SERCA activity resulted in a delayed G1 to S phase transition in
the cell cycle [33]. SERCA dysfunction has been also reported
following exposure of pancreatic beta cells to cytokines [48].
However, in our experiments not only the function, but also the
expression of SERCA decreased upon Poly I:C treatment, which
could result in disturbance of cell cycle regulation [33]. Exposure
of hPAECs to Poly I:C in fact disturbed the regular cell cycle.
Figure 6. Inhibition of hPAEC proliferation, increase of FITC-dextran permeability and disruption of intercellular junctions by the
SERCA blocker. (A) The SERCA blocker, BHQ inhibited hPAECs proliferation in a concentration-dependent manner. The bar graph summarizes 3
independent experiments each performed in triplicates. (B) BHQ significantly increased the FITC-dextran permeability of hPAECs. The bar graphs
summarize 3 independent experiments each performed in triplicates. (**p,0.01, ***p,0.001 compared to Vehicle control). (C) Confocal microscopic
images revealed that BHQ reduced the VE-cadherin signal compared to control, similar to Poly I:C and LY-294002. Nuclei were counterstained with
DAPI (blue).
doi:10.1371/journal.pone.0063776.g006
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Furthermore, a dose and time-dependent accumulation of
hPAECs in the G1-phase was observed. This increase was
accompanied by decrease in the number of cells both, in S and
in G2/M phase, indicating that the cell cycle is arrested. In
addition, Poly I:C treatment resulted in inhibition of proliferation,
with no increase in apoptosis (Figure S2, Methods S1). As the Ca2+
homeostasis of the cells was altered through affecting the SERCA
pump but without change in apoptosis, we conclude that Poly I:C
causes Ca2+ mishandling, due to SERCA downregulation and
functional inhibition, thereby leading to G1 arrest and finally to
inhibition of hPAEC proliferation.
In conclusion, our data suggest that exposure to synthetic
double-stranded RNA modulates Ca2+ signaling in human
pulmonary artery endothelial cells by inhibiting their Ca2+-
Figure 7. siRNA treatment against SERCA3 protects the hPAECs from Poly I:C induced permeability and junctional changes. (A)
siRNA silencing of SERCA3 abolished the FITC-dextran permeability increase of hPAECs caused by Poly I:C. The bar graphs summarize 4 independent
experiments each performed in triplicates. (*p,0.05 compared to siCTL - Vehicle control, #p,0.001 compared to siCTL - Poly I:C). (B) mRNA and
protein level of SERCA3 upon treatment of siCTL and siSERCA3. (C) Representative confocal microscopic images reveal that siSERCA3 treated hPAECs
respond with less VE-cadherin signal loss compared to siCTL treated hPAECs upon 24 h Poly I:C stimulation. Nuclei were counterstained with DAPI
(blue).
doi:10.1371/journal.pone.0063776.g007
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extruding pump, the sarco-endoplasmic Ca2+ ATPase. The cell
cycle and the cell monolayer integrity are affected resulting in an
accumulation of the hPAECs in G1 phase of the cell cycle. The
circulating dsRNA due to reducing phospholamban phosphory-
lation may alter intracellular Ca2+ homeostasis and thus cell
growth, leading to endothelial cell dysfunction. It is tempting to
hypothesize that circulating extracellular RNA (e.g. in viral
infection) acts as a barrier disrupting agent and contributes to
the development of human pulmonary vascular dysfunction.
Supporting Information
Figure S1 Bar graphs represent the TLR3 gene fold
change compared to untreated control after 24 hours of
Poly I:C or L-DNA stimulation.
(TIF)
Figure S2 Bar graphs represent percentage of apoptotic
cells as measured by PI and Annexin V staining upon 24
hours of stimulation (Stauro - staurosporin; ***p,0.001
as compared to Control).
(TIF)
Methods S1 Quantitative RT-PCR of TLR3 and apopto-
sis measurements in hPAECs.
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